Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyGemma Gatta, Alice Nennecke, Riccardo Capocaccia et al.|The Lancet Oncology|2017Cited by 510
Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5Rafael Marcos‐Gragera, Hermann Brenner, Véronique Bouvier et al.|European Journal of Cancer|2015Cited by 90
Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based studyPaolo Baili, Sabine Luttmann, F. Di Salvo et al.|European Journal of Cancer|2015Cited by 79
Epidemiology of rare cancers and inequalities in oncologic outcomesGemma Gatta, Silvia Rossi, Annalisa Trama et al.|European Journal of Surgical Oncology|2017Cited by 74
Cancer prevalence estimates in Europe at the beginning of 2000Gemma Gatta, Fabio Falcini, Sandra Mallone et al.|Annals of Oncology|2013Cited by 44